Atlas Trials

Validate Smart Breath Analyzer as Screening Tool for Diabetic, Hepatic, Renal, Lung, and Other Metabolic Disorders

Clinical trial NCT07646015 · COMPLETED

Trial details

NCT number
NCT07646015
Sponsor
Respyr
Status
COMPLETED
Study type
OBSERVATIONAL
Diabetes Mellitus, Type 2Liver DiseasesKidney DiseasesLung DiseasesMetabolic DiseasesHealthy Volunteers
Start date
2022-10-03
Primary completion
2023-10-03
Enrollment
3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.